Article ID Journal Published Year Pages File Type
3964118 Journal of Reproduction and Contraception 2015 8 Pages PDF
Abstract

ObjectiveTo study clinical significance and the difference of calcitonin receptor stimulating peptide-3 (CRSP-3) expression in placenta tissue between normal pregnancies and patients with preeclampsia.MethodsCRSP-3 expression position in placenta tissues of 50 cases with preeclampsia (preeclampsia group: 25 cases of mild preeclampsia and 25 cases of severe preeclampsia) and 30 cases of normal late pregnancy (control group) was detected using immunohistochemical methods. CRSP-3 mRNA and protein expression in placenta tissues was detected using Real-time PCR and Western blotting method.ResultsSyncytiotrophoblast and cytotrophoblast cells expressed CRSP-3 in placenta tissue of preeclampsia and normal pregnancy patients. The expression levels of CRSP-3 mRNA and protein in placenta tissue of preeclampsia patients were higher than those in control group (P<0.05). The expression levels of CRSP-3 mRNA and protein in placenta tissue of severe preeclampsia patients were higher than those in control group (P<0.01) significantly. The expression level of CRSP-3 mRNA and protein in placenta tissue of severe preeclampsia group was slightly higher than that in mild preeclampsia group, but there were no statistical differences between the two groups (P>0.05).ConclusionThe up-regulation of CRSP-3 in placenta of preeclamptic patients may be associated with the etiology of preeclampsia, but may have no relation with progress and degree of preeclampsia.

Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health